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TITLE : Limb Salvage Procedures In Diabetic Foot Ulcers – A Prospective 
Analytical Study 
AIM OF THE STUDY 
To assess the usefulness of various screening procedures and limb salvaging 
interventions in diabetic foot ulcers and to bring out strategies for prevention of 
future foot problems. 
PATIENTS AND METHODS 
This study was conducted at Government Rajaji Hospital, Madurai from August 
2009 to August 2011. It included 100 patients with diabetic foot ulcers. Sensory 
neuropathy,vasculopathy and infection were evaluated using clinical and 
noninvasive methods. In infected ulcers wound healing between retrograde venous 
perfusion and intravenous antibiotics were compared. In non infected ulcers, 
wound healing was compared between platelet derived growth factor and normal 
saline dressings. 
DATA COLLECTED 
Age , sex , duration of diabetes ,treatment taken, smoking, hypertension and other 
comorbidities, were noted. Presence of sensory neuropathy, vasculopathy and 
infection were recorded. The ulcer area was assessed on days 0,7,14,21,28 in all 
the patients and were categorized as completely healed, improved , partially healed 
and worsened . 
RESULTS AND ANALYSIS 
Most of our patients had type 2 diabetes and the mean duration was more than 7 
years . Sensory neuropathy and vasculopathy were present in 100% and 80% of 
our patients respectively .In platelet derived growth factor application, about 80% 
of the ulcers improved and the reduction in ulcer area was more than 40cm2 by 4 
weeks .By retrograde venous perfusion ,80% of ulcers improved and the reduction 
in ulcer area was around 41cm2 .All the patients are screened for the presence high 
risk pressure points and special foot wears were prescribed . 
CONCLUSION 
By adequate control of blood sugar,proper screening, appropriate foot care ,and 
judicious use of modalities like platelet derived growth factor application and 
retrograde venous perfusion of antibiotics most of the diabetic limbs can be saved. 
KEYWORDS: diabetic foot, platelet derived growth factor, retrograde venous 
perfusion, sensory neuropathy, vasculopathy. 
  
INTRODUCTION 
Diabetes mellitus virtually affects every organ system in the body and it 
can be well said that “Knowing diabetes, is like knowing the entire human 
body”. The Ancient Greek physician Aretaeus of Cappadocia (81 -138AD) was 
the first to use the term diabetes. The word diabetes is perhaps derived from a 
Greek word signifying a siphon.  In 1920, Frederick  Banting , Charles Best 
and John James Macleod first isolated insulin from  the pancreas and named it 
isletin.  
The world is currently experiencing a pandemic of diabetes mellitus, 
particularly of type 2 or adult onset.  The magnitude of the problem of diabetes 
is enormous. By 2030 there will be 366 million diabetics in the world which is 
mainly due to longer life expectancy and change in dietary habits. India will 
have the largest number of persons with diabetes. Majority of these patients 
will be in the age group of 35 to 45 years. Approximately 15% of these patients 
will develop foot problems. And 1% of these patients are likely to lose a limb 
due to some foot pathology or the other. However, the blessing in disguise is 
that the foot problems seen in indian diabetic patients are mainly neuropathic- 
infective and not ischemic – infective. The latter are extraordinarily more 
difficult to treat than neuropathic ulcers.  
  
 It is a sad fact  that , as of today a regular foot examination and monitoring 
is not routinely practiced by our people. In fact, the routine policy is – “No 
complaints – No examination”. However, by the time the patient complains of 
some symptoms, the pathology is advanced and foot salvage becomes extremely 
difficult. Early detection and attention to warning signals in the foot definitely can 
salvage the limbs to a greater extent. 
 DIABETIC FOOT  
Definition 
The diabetic foot may be defined as a group of syndromes in which 
neuropathy, ischemia, and infection lead to tissue break down resulting in 
morbidity and possible amputation”.  
WHO definition :   
“The foot of a diabetic patient that has the potential risk of pathologic 
consequences including infection, ulceration and / or destruction of deep 
tissues associated with neurologic abnormalities, various degrees of peripheral 
vascular disease and or metabolic complications of diabetes in the lower limb”. 
 
 
 
  
Government Rajaji Hospital, Madurai. 
This renowned institution which is well known for its academic and 
research activities has a very good infrastructure for managing diabetes and its 
associated complications. In our institution we have a diabetology department 
and also a diabetic foot clinic for effective management of foot problems in 
diabetes. 
Department of Diabetology 
This department has a well equipped infrastructure, which has been 
rendering its services to all the diabetics of southern districts of  Tamilnadu 
from the year 2000 onwards . It is manned by fully qualified diabetologists 
who are treating about 800 to 1000 diabetic patients per day as outpatients. 
Various screening tools like biothesiometer, doppler probe and other 
sophisticated equipments are available in this department. Experts in the field 
of dietics and podiatry educate our diabetic patients to have a better quality of 
life. 
Diabetic foot clinic 
In the department of General surgery, we have a separate diabetic foot 
clinic in which we conduct separate outpatient clinics once a week. Every week 
we do get around 10- 15 diabetic patients with foot problems who will get 
  
either an outpatient or inpatient treatment depending on the magnitude of their 
problem. In addition to this, patients with diabetic foot ulcers are being 
admitted in regular OPD’s also. All these patients are treated according to 
current guidelines and recommendations. There is a separate physiotherapy 
department where proper foot wear is being dispensed for the diabetic patients 
with foot problems. 
 
 
 
 
 
 
 
 
 
 
 
  
AIM OF THE STUDY 
To assess the usefulness of various screening procedures and limb salvaging 
interventions in diabetic foot ulcers and to bring out strategies for prevention of 
future foot problems. 
1. To evaluate the incidence of sensory neuropathy, vasculopathy, infection 
and its association to diabetic foot ulcers. 
2. To compare the effectiveness of wound healing in diabetic foot ulcers 
a. Between application of Platelet derived growth factor and Saline 
dressings. 
b. Between Retrograde venous perfusion and Intravenous administration 
of antibiotics. 
 
 
 
 
 
 
 
 
  
MATERIALS AND METHODS 
This study was conducted at Government Rajaji Hospital, Madurai from 
August 2009 to August 2011.  It included 100 patients with diabetic foot ulcers 
who got admitted in surgical wards. Patients treated as outpatients were 
excluded from the study .The diagnosis of diabetes was verified for all patients 
using the criteria set forth by the World Health Organization which includes, 
treatment with insulin, two random blood glucose measurements greater than 
200mg/dl or a fasting blood glucose greater than 126mg/dl. Age and sex of the 
patients, duration of diabetes and treatment taken were recorded. Presence of  
smoking, hypertension and other comorbidities   were also  noted. Sensory 
neuropathy was evaluated using foot imprints with harris mat and 
biothesiometry. The areas of high pressure in the foot which is marked by the 
presence of more ink in the imprints and a vibration perception threshold of 
more than 25v in biothesiometry are taken as presence of sensory neuropathy. 
 A working diagnosis of lower extremity ischemia was made by a 
combination of clinical and noninvasive vascular studies. Clinical signs were 
based on the absence of one or more foot pulses of the involved foot. 
Noninvasive criteria included an Ankle – Brachial index (ABI) of < 0.80. 
Clinical signs and / or the presence of abnormal noninvasive values make a 
diagnosis of lower extremity vascular insufficiency.  
  
The diagnosis of infection was made using clinical criteria. Wounds with 
frank purulence and / or two or more of the following local signs were 
classified as “infected”. These signs include warmth, erythema, lymphangitis, 
lymphadenopathy, edema, and loss of function. Culture and sensitivity of the 
wound discharge was also done. Effective wound debridement was done in all 
the cases. And all the patients were treated with insulin. 
In infected cases the role of retrograde venous perfusion of antibiotic 
was compared with intravenous antibiotic with respect to the decrease in ulcer 
area on days 0, 7, 14, 21, 28. Before the institution of retrograde venous 
perfusion assessment of vascular status of the limb was done by doppler study. 
Combination of Heparin(100units), Sodium bicarbonate(2ml), Piperacillin 
+Tazobactum( 4.5g) and  Lignocaine (4ml) made to 120ml with normal saline 
was injected in to leg vein with application of tourniquet at the thigh  for 20 
minutes. Intravenous piperacillin+tazobactum alone was given in the 
intravenous group. Antibiotics were given for a period of 14 days in both the 
groups. The inclusion criteria were (a) patients with infected non healing 
diabetic foot ulcer (b) absence of venous thrombosis in the affected limb and 
(c) nonedematous limbs. The exclusion criteria were, presence of deep vein 
thrombosis, gangrene and difficulty in venous canulation. 
  
  In non infected diabetic foot ulcers the effectiveness of wound healing 
was compared between the application of platelet derived growth factor and 
saline dressings. Daily application of platelet derived growth factor was done 
for a period of one month and normal saline dressing in the control group and  
the ulcer area was assessed on days 0,7,14,21,28 in both the groups.  
Ulcer Healing in all the groups were categorized as A-Completely 
healed, B-Improved (>80% reduction in ulcer area), C-Partially healed (<50% 
reduction in ulcer area ) and D-Worsened . Other treatment modalities like skin 
grafting and amputation were also recorded. 
Statistical Tools  
The information collected regarding all the selected cases were recorded 
in a Master Chart. Data analysis was done with the help of computer using 
Epidemiological Information Package (EIP 2010) developed by Centre for 
Disease Control, Atlanta. Using this software range, frequencies, percentages, 
means, standard deviations, chi square and 'p'  values were calculated. Kruskul 
Wallis chi-square test was used to test the significance of difference between 
quantitative variables and Yate’s chi square test for qualitative variables. A 'p' 
value less than 0.05 is taken to denote significant relationship. 
 
  
DIABETIC FOOT – MORBID ANATOMY 
A sound knowledge of anatomy is essential while treating diabetic foot 
complications, particularly infections. Unless aggressively and adequately 
treated for infections, “the patient pays through his foot’ and may ultimately go 
home without it”. 
Peculiarities of the foot 
 “Foot is a highly complex design of nature, energy efficient, shock proof 
and has resilient biomechanism, adopted to weight bearing and locomotion on 
uneven surfaces”. The foot is more peculiar so that it a vulnerable target in 
diabetes. It is the farther point from the heart and hence the commonest site for 
arterial insufficiency. It is the most dependent part of the body there by a 
favorite site for venous insufficiency. It is the maximum weight bearing part 
and hence there are multiple pressure points which are poor prospects for 
survival of free skin grafts. The foot is vulnerable to injuries. It is also a 
common site for peripheral neuropathy, wherein the foot is vulnerable to 
physical and thermal injuries, small muscle atrophy and deformities as well as 
trophic changes. The foot is also prone to footwear related problems like 
blisters (new shoes), corn or callosities, ingrown toe nail, hallux valgus and  
 
  
SKELETON OF FOOT  
 
 
 
  
hammer toe. Due to socio cultural practices, there are problems related to bare 
foot walking.  
Skin , Nails and Subcutaneous tissues of the foot 
 The dorsal skin is thinner (2mm thick), lax and can be pinched, while the 
plantar skin is thick (5mm) and cannot be pinched. The foot has a thick stratum 
corneum and a thin dermis. The skin is rich in sweat glands on the plantar skin. 
The dermis is bound to underlying fascia to improve grip and to prevent 
gliding or sliding. Infections of sole tend to point to the dorsum, because of the 
thick plantar skin. The epidermis gets transformed into the nail matrix. It has 
three ill- defined layers dorsal, intermediate and ventral layers. It is firmly 
attached to the epithelium of nail bed. The margins of the nail are overhung by 
skin folds predisposing to ingrown toe nails.The plantar subcutaneous tissue is 
more fibrous. The fluid fat is loculated by fibrous septa to provide shock 
absorption and to prevent gliding or sliding of plantar skin. 
Skeleton and fascia of the foot 
 The skeleton of the foot is shaped to form arches and adjust to uneven 
surfaces. There are 7 tarsal bones, 5 metatarsals and 14 phalanges.The 
superficial fascia of the sole is fibrous and dense. Fibrous bands bind the skin 
to deep fascia or plantar aponeurosis. The fibrous bands divide the  
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subcutaneous fat into small compartments which serve as cushions and 
reinforce the spring effect of the arch during walking, running, jumping, etc.  
The fascia is thick over weight bearing parts. It contains cutaneous nerves and 
vessels. The thickened central part of the deep fascia is the plantar aponeurosis. 
The plantar aponeurosis fixes the skin of the sole, protects deeper structures 
and helps in maintaining the longitudinal arches of the foot. It also gives origin 
to the muscles of the first layer of the sole.                  
Ligaments of the foot 
 The ligaments maintain the arches and stability. They have a springing 
effect in locomotion and also help in shock absorption. The ligaments of the 
foot are long plantar ligament, plantar calcaneocuboid (shortplantar) ligament, 
plantarcalcaneonavicular (spring) ligament, deltoidligament (medial), 
transverse metatarsal ligament, interosseous ligament.  
Muscles and tendons of the foot 
 There are four layers which help in movement and grip and have a 
cushioning effect thereby protect nerves and vessels and they suspend arches. 
First layer includes abductor hallucis longus, flexor digitorum brevis, abductor 
digiti minimi. Second layer is made of flexor accessorium (quadratus 
plantaris), tendons of flexor hallucis longus, flexor digitorum longus and the  
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lumbricals. Third layer is constituted by the flexor hallucis brevis, , transverse 
and oblique heads of adductor hallucis, flexor digiti minimi brevis. The  fourth 
layer is mainly formed by the interrossei. 
Musculo- fascial compartments of the foot 
 There are four compartments, formed by vertical septa from the plantar 
aponeurosis extending deep. They are the medial, central, lateral and 
interosseous compartments. The medial compartment contains medial plantar 
nerve, artery, vein, and the central (larger) compartment contains lateral plantar 
nerve, artery and vein. 
Nerves of the foot 
Saphenous nerve arises from the femoral nerve. It supplies medial aspect of 
the foot up to the first metatarsal. Superficial peroneal (fibular) nerve is the 
smaller terminal branch of the common peroneal nerve. It gives cutaneous 
branches to most of the dorsum of foot including digital branches to medial 
side of great toe, adjacent sides of second, third, fourth and fifth toes. Deep 
peroneal (fibular) nerve is the terminal branch of the common peroneal nerve. 
It supplies extensor digitorum brevis and gives cutaneous branch to the 
adjacent side of great and second toes. Medial plantar nerve is the largest 
terminal branch of the tibial nerve. It supplies abductor hallucis, flexor  
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digitorum brevis, flexor hallucis brevis and first lumbrical muscle. Cutaneous 
branches supply skin of the medial part of the sole and medial three and half 
toes. Lateral plantar nerve  is the smaller terminal branch of tibial nerve. The 
main trunk supplies flexor digitorum accessorius, abductor digiti minimi and 
skin of the sole. It divides into superficial and deep branches. Sural nerve 
arises from tibial and common fibular nerves and runs along the short 
saphenous vein. It supplies lateral side of the foot and fifth toe and all intrinsic 
muscles of the foot (S2 and S3).  
Arterial tree 
 The dorsalis pedis artery is a continuation of anterior tibial artery and it 
runs between tibialis anterior and extensor hallucis longus tendons. It may be 
absent in about 5% of population. It gives arcuate artery, supplying the dorsum 
of foot and toes. The dorsalis pedis artery dips deep in the first inter-metatarsal 
space to form the plantar arch, by joining the medial and lateral plantar arteries. 
The posterior tibial artery, runs behind the medial malleolus and divides into 
medial and lateral plantar arteries, supplying the sole and toes. The plantar arch 
is formed by the medial and lateral plantar arteries with contribution from 
termination of the dorsalis pedis artery. The digital arteries arise from the 
plantar arch (plantar aspect) and arcuate artery (dorsally). 
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Venous drainage 
 The dorsal venous arch lies in the dorsum of foot over the proximal parts 
of the metatarsal bones. It receives four dorsal metatarsal veins. These 
metatarsal veins are formed by the union of two dorsal digital veins.The long 
saphenous vein is formed by the union of medial end of the dorsal venous arch 
and the medial marginal vein. The medial marginal vein drains the medial side 
of the great toe. The short saphenous vein is formed by the union of lateral end 
of dorsal venous arch and lateral marginal vein. The lateral marginal vein 
drains the lateral side of the fifth toe. Both the saphenous veins connect to deep 
veins through the perforating veins. 
Lymphatic drainage 
 Superficial lymphatics drains along both the saphenous veins, short 
saphenous zone into popliteal group and long saphenous zone into inguinal 
group. Deep lymphatics drain along the arteries to both popliteal and inguinal 
groups. 
Arches of foot 
The arches help to adjust to uneven surfaces. The presence of arches 
makes the sole concave and this concavity protects the neuro-vascular 
structures. They are medial and lateral longitudinal arches and the anterior and 
posterior transverse arches  
  
Anatomical principles of surgical incisions 
 There are some anatomic principles one need to keep in mind while 
making incisions on the foot. 
• Avoid neuro-vascular injury. 
• Avoid weight- bearing points. 
• Make liberal counter incisions. 
• Deroofing should be liberal. 
• Excise metatarsal head, while doing toe amputation for better 
realignment of toes. 
 
 
 
 
 
 
 
 
  
DIABETIC FOOT - PATHOPHYSIOLOGY   
       Diabetes mellitus is associated with more than half of all non-traumatic 
lower limb amputations. The major pathophysiological factors are ischemia, 
neuropathy and wound infection. They operate concurrently and 
sequentially, enhancing the risk for amputation fifteen fold in diabetic 
subjects compared to non diabetics. Since the diabetic foot is the sequelae of 
interaction of multitude of factors, intervention must be directed towards 
correction of all causative factors. 
Diabetic neuropathy 
The most important factor leading to amputation for the person with 
diabetes is peripheral neuropathy and the resulting insensitive foot. Diabetic 
neuropathy affects sensory, autonomic and motor neurons of the peripheral 
nervous system, which is to say that every type of nerve fibre is affected. 
Diabetic peripheral neuropathy may be divided into two main types, acute 
sensory neuropathy and chronic sensorimotor  neuropathy( most common ). 
 Biochemical dysfunctions leading to neuropathy includes increased 
advanced glycosylation end products( AGE’S),defective polyol pathway, neuro 
vascular alterations and impaired resistance to oxidative stress. The 
manifestations of sensory neuropathy are paresthesia, reduced pain perception, 
loss of joint sense, loss of vibration sense, glove and stocking anaesthesia, 
  
charcot joints. Motor neuropathy presents as weakness of muscles, paralysis of 
small muscles of foot producing deformed toes. Autonomic neuropathy is 
characterized by the micro circulatory derangement of the tissues of the foot. 
There will be abnormal sweating and in some absence of sweating, dry foot 
with lot of cracks in the sole, calcification of medium sized arteries and loss of 
thermoregulation.                                     
Development of neuropathic ulcer 
Increased load 
↓ 
Unaware due to insensate foot 
↓ 
Focused inflammation 
↓ 
Plaque of keratin 
↓ 
Tissue breakdown 
↓ 
Cavity as nidus of sepsis 
↓ 
Invasive infection 
↓ 
Trophic ulcer 
 
  
Diabetic Macroangiopathy 
Involvement of the major blood vessels is common in diabetes. The 
abdominal aorta and its branches are affected. The atherosclerosis is 20 times 
more common in the diabetics than the non diabetics. Calcification of the 
artery is also a common feature of diabetes. The media of the artery is 
calcified, which is called as Monckeberg sclerosis and this is due to 
neuropathy. 
Calcification makes the vessel rigid and this gives a falsely elevated 
perfusion pressure. The crucial artery is the popliteal artery and its narrowing 
produces foot gangrene. Diabetes and smoking are the strongest risk factors for 
peripheral arterial disease. It is important to note that diabetes is most strongly 
associated with femoral – popliteal and tibial ( below the knee ) peripheral 
arterial disease.  Diabetic  peripheral arterial disease  has predilection for tibial 
and peroneal vessels  but  dorsalis pedis artery, the distal posterior tibial artery 
and the plantar arteries are usually spared. Diabetic patients with 
atherosclerotic peripheral vascular disease also show a diminished ability to 
establish collateral circulation. 
 
 
  
Microvascular changes  
Peculiar to diabetes is development of microvascular dysfunction, which 
begins early in diabetic life. It is frequently seen in the capillaries and arterioles 
of kidneys, retina and peripheral nerves, but spares no organ. In diabetes 
RBC’s become flat and rigid and the blood is more viscous which are the major 
factors for microvascular  impairment. Abnormalities in nitric oxide pathway, 
abnormal vasoconstrictor prostanoids, intracellular signaling , reduction in 
sodium- pottasium ATPase activity, and advanced glycosylation end products 
are responsible for microvascular changes. 
Vascular diseases: 
The frequently associated risk factors for diabetic vascular disease include 
smoking, hypertension, hyperlipidemia, insulin resistance with compensatory 
hyperinsulinemia, severity and duration of diabetes, age and genetic factors. 
Smoking enhances the risk of peripheral vascular disease more than hundred 
times compared to non – diabetic non smokers. However, cessation of smoking 
has been associated with a decrease in the progression of atherosclerosis. 
 Hypertension is twice as common in diabetics as compared to non 
diabetics; roughly one third to one half of diabetics have hypertension. Systolic 
hypertension has been linked with disease of proximal blood vessels.  
  
Diabetes and endothelial cell dysfunction 
The mediator of endothelial cell dysfunction in diabetes is derangement 
of nitric oxide bioavailability. Nitric oxide inhibits vascular smooth muscle cell 
migration and proliferation and limits platelet activation. Diabetes stimulates 
proatherogenic activity in vascular smooth muscle cells.  
Diabetes, coagulation and rheology 
Diabetes leads to hypercoagulable state. It is associated with the 
increased production of tissue factor by endothelial cells and vascular smooth 
muscle cells as well as increased plasma concentration of Factor VII. 
Hyperglycemia is also associated with a decreased concentration of 
antithrombin and protein C, impaired fibrinolytic function, and excess 
production of plasminogen activator inhibitor. Platelet aggregation is enhanced 
in diabetes. Platelet in diabetic patients also have increased expression of 
Glycoprotein IIb/ IIIa receptors, which are important in thrombosis via their 
role in platelet adhesion and aggregation. 
Infection  
Infection is defined by invasion of the tissues with proliferation of 
microorganisms causing tissue damage with or without an associated 
  
inflammatory response by the host. Foot sepsis accounts for about 70% of all 
infections. Adherence of granulocytes and other WBC functions like 
phagocytosis are impaired in diabetes. T cell function is impaired and cell 
mediated immunity is depressed. Hyperkeratosis in foot is mistaken for a corn 
and removing it using rusted nail and safety pin is the foremost reason leading 
to amputation. Absent sweating leads to cracks and fissures in foot which are 
portals of infection. Organisms may be causative , commensal, contaminant or 
coexisting polymicrobial. Most common is polymicrobial infection. 
Staphylococcus aureus and Beta hemolytic streptococci are the most 
commonly involved pathogens in acute infections. In Chronic wounds, 
Enterococci, Enterobacteriaceae, Obligate anaerobes, Pseudomonas, Fungi are 
the pathogens involved.  
Biomechanical aspects: 
 Combination of neuropathy and trauma results in tissue breakdown. The 
atrophy of the intrinsic muscles of the foot, predominantly plantar flexors of 
the toes alters the flexor / extension balance at the metatarsophalangeal joints 
and causes clawing of the toes and prominence of the metatarsal heads. 
Alterations of foot shape results in increased plantar pressure. A majority of 
wounds on insensitive foot are not caused by accidental injury or ischemia but 
from continuous pressure. Often moderate stress as occurring during  
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locomotion on the same part of the insensitive foot leads to callus formation 
and ulcer. The presence of callus may exacerbate the problem both acting as a 
foreign body and by increasing the plantar pressure. 
CHARCOT FOOT: 
 Charcot foot or neuroarthropathy is defined as a relatively painless, 
progressive, degenerative arthropathy of single or multiple joints caused by 
underlying neuropathy. Charcot  neuropathy is characterized by simultaneous 
presence of bone and joint destruction, fragmentation and remodelling. 
Diabetes is the commonest cause of charcot foot and most patients have a 
dense neuropathy but good circulation. Walking on an insensitive foot leads to 
excessive and repetitive stress to bone causing micro fracture and finally bone 
and joint destruction. Diabetic neuropathy and presence of auto 
sympathectomy lead to peripheral vasodilatation (warm foot). A significant 
arteriovenous shunting takes place leading to abnormal bone cell activity 
(osteoclastic) and eventual resorption and weakening of bone. Ultimately the 
foot shape is deformed and runs into a bag of bones. 
 Bone and joint damage in the metatarsal region is the commonest site of 
involvement and leads to the two classical deformities. 
  
1. Rocker bottom deformities in which there is displacement and 
subluxation of the tarsus downward. 
2. Medial convexity, which results from displacement of the talo- 
navicular joint or from tarso-metatarsal dislocation. 
Both are often associated with a bony prominence which is very prone to 
ulceration. Healing is notoriously difficult. If these deformities are not 
diagnosed early and accommodated in properly fitting footwear, ulceration at 
vulnerable pressure points often develops. It is not uncommon to mistake 
acute charcot foot for cellulitis and osteomyelitis. If the affected foot is 
elevated, the erythema of charcot foot  will recede whereas that of cellulitis 
will persist. Acute charcot foot should not be mistaken for a cellulitis and 
operated . 
 Plain X-ray of the foot will show demineralization, bone destruction and 
periosteal reaction. Marked osseous resorption of bone results in “pencil 
pointing” and “sucked candy”  deformities  of  the  metatarsal  heads and 
shafts. In the largest joints of the foot there will be destruction of bone and new 
bone formation. It is a dictum that a “warm swollen foot in a diabetic with 
neuropathy without local and systemic signs of infection, charcot foot must be 
considered until proven otherwise”. 
  
Osteomyelitis 
Osteomyelitis should be suspected if the ulcer does not heal for more 
than 6 weeks of appropriate care and off loading, and if there is swollen foot 
with ulcer, sausage toe, high WBC count or inflammatory markers. 
Radiographic evaluation is needed if osteomyelitis is suspected. Bone scan 
findings will be positive within 24 hrs while a plain X-ray will take 10 – 14 
days to show any abnormality. There will be soft tissue swelling and periosteal 
elevation in acute osteomyelitis and Osteopenia, osteolysis, and tapering of 
bones in chronic osteomyelitis. Any ulcer in which the bone is felt on probing 
with a sterile metal probe is likely to have osteomyelitis. 
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DIABETIC FOOT -CLINICAL ASSESSMENT  
Clinical assessment of Neuropathy 
1.Filament test- Semmes-Weinstein monofilaments is used to detect the 
diminished sensation of foot.  
Semmes-Weinstein monofilaments 
The monofilament is a valuable and easy to use tool. The monofilament 
is a long nylon wire, the tip of which gives a force of 10 grams. It is 
pressed against the skin to the point of buckling for atleast one second. 
The points of testing are plantar aspects of 1st , 3rd  and 5th  digits, the 
plantar aspect of 1st , 3rd  and 5th  metatarsal heads, plantar mid foot 
medially and laterally and the plantar aspect of heel (10 sites totally) . 
Neuropathy is said to exist when 4 out of these 10 sites show absence of 
sensation when the wire is pressed against the skin. 
2.Testing for vibration sense in toes and over the Malleoli 
Biothesiometer  
This is also called as vibration perception threshold meter. This has a 
hand held probe whose tip vibrates at 100HZ. The probe is applied to a 
part of the foot, usually on the big toe. The probe can be made to vibrate 
at increasing intensity by turning a dial. The voltage supplied to the 
probe can be adjusted from 0 -50 V. The probe is placed against the skin  
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and the voltage is increased until the patient perceives the vibration. 
Mean of three readings is used to determine the vibration perception 
threshold for each foot. Normal reading is less than or equal to 25 V. 
  3. Loss of joint position is common in diabetic neuropathy. Joint sense 
of great toe is tested.  Severe neuropathy produces small muscle wasting 
in the foot which leads to collapse of arches and deformity of toes. These 
are precursors for ulcer formation. Absence of sweating makes the foot 
dry and prone for infection and cracks. Prominent long saphenous vein is 
an index of autonomic microcirculatory dysfunction. This is a valuable 
clinical sign (J D Ward sign) of microcirculatory arterio venous shunting.. 
 Clinical assessment of vascular disease 
It starts with inspection of the foot for hue of toes, nicotine staining of 
fingers, the thinning of skin due to loss of subcutaneous tissue and acral 
ulcers. Palpation of pulses (dorsalispedis, popliteal and femoral)  
remains the corner stone of screening for peripheral vascular disease. 
Absence of distal pulses is a sure sign of significant arterial disease. 
However presence of palpable pulse does not absolutely exclude 
vascular disease.  
 
  
 
 
 
 
 
  
 Ankle brachial pressure index( ABI ) 
It is a simple method of assessing vascular insufficiency. It is obtained 
by dividing Ankle systolic pressure by Brachial systolic pressure. 
Normal values are 1+ 0.1. However ABI can be deceptive because 
calcification of vessels in diabetics can lead to falsely elevated ABI. All 
diabetics must have an annual assessment of ABI. 
Indications for ABI monitoring  
1. All those with type 1 diabetes older than 35 years or who have had 
diabetes for over 20 years at base line.  
2. All patients older than 40 years at base line with type 2 diabetes.  
3. Any diabetic patient who has newly detected diminished pulses , 
femoral bruits or a foot ulcer. 
4. Any diabetic with a leg pain of unknown etiology. 
If ABI is more than 0.9 repeat every 2 -3 years. If ABI is 0.5 -0.89 
repeat the measurement  within 3 months and treat cardiovascular risk 
factors. If ABI is less than 0.5, refer for vascular work up and 
management. If an incompressible artery with an ankle pressure above 
300mmHg or an ankle pressure 75 mmHg above arm pressure is found, 
the measurement should be repeated in 3 months. If still present refer for 
vascular work up. 
  
Infection  
Infected ulcers are often asymptomatic in neuro ischemic foot of 
diabetics. The categorization of wound infection can be mild, moderate 
and severe. Mild infections are superficial infections confined to the skin 
and subcutaneous tissue with minimal or no purulence or cellulitis. 
Moderate infections are deep and may involve  fascia, muscles, tendons, 
joints and bones. They may present as cellulitis of less than 2cm 
diameter, plantar abscess and with systemic symptoms. Severe 
infections are deep with cellulitis more than 2cm,lymphangitis, gangrene  
and or necrotizing fascitis, threatening limb loss and causing systemic 
toxicity.  
INTEGRATED EXAMINATION OF DIABETIC FOOT  
In practice the examination of the foot should be divided into four main 
parts: inspection, palpation, neurological examination and vascular 
assessment. 
 
 
 
  
1. Inspection  
The foot should be fully inspected including dorsum, sole, back of 
the heel and inter digital areas with full assessment regarding colour(as 
an indicator of ischemia), deformity, swelling, callus, skin breakdown, 
infection, necrosis 
2. Palpation 
Pulses should be palpated and skin temperature compared between 
both feet with the back of the examining hand. The measurement of the 
skin temperature is particularly helpful in the management of the charcot 
foot where a digital skin thermometer is useful. 
3. Neurological examination: 
Peripheral neuropathy should be detected either by using the 
monofilament or biothesiometer or by performing a simple sensory 
examination. 
4. Vascular status: 
All the peripheral pulses must be examined and compared with the 
normal limb. With regard to lower limb, femoral, popliteal, dorsalis 
pedis and posterior tibial arterial pulses must be examined. 
  
DIABETIC FOOT – INVESTIGATIONS 
 
LABORATORY  TESTING : 
1. Blood sugar monitoring is the corner stone in management of any 
diabetic problem. A fasting and postprandial plasma glucose monitoring is 
essential in all diabetic foot patients. HBA1c monitoring is widely practiced 
nowadays.  
2. Bacterial culture 
Superficial swabs are not useful. Necrotic tissue should be removed 
before taking a swab. Culture of swabs taken from the deeper part of the 
wounds will be effective in identifying the pathogens. 
IMAGING  STUDIES : 
Plain Radiographs are used to detect osteomyelitis, osteolysis, 
fractures, dislocation, etc . In a CT scan, the resolution  of  bone   with  
osseous  fragmentation and  subluxation are  well  visualized. MRI aids  in  
diagnosis  of   osteomyelitis, deep abscess, septic  joint  and  tendon rupture. 
Three phase Technetium  Scans  are used  for early  detection  of  
osteomyelitis,  fractures ,charcot arthropathy.  Indium III  Leucocyte  scans  
and Tc 99 labelled White Cell Scan – differentiates  osteomyelitis  and  
neuropathic arthropathy. Duplex ultrasound and Arteriography are used  to 
detect arterial stenosis.   
  
Gait analysis and  Thermography   
A walking cycle by definition is the time between the heel making 
contact with the ground and the same heel again coming in to contact with the 
ground. In diabetes thickening of skin of sole due to abnormal weight bearing 
and infection under thick skin leads to altered gait. Neuropathy leading to claw 
toes and bent toes can lead to ulcers. Hence gait analysis in diabetics is 
mandatory for early detection of neuropathy.   
Moderate repetitive stress with repetitive shearing force produces the 
typical neuropathic ulcer. Frictional forces occurring below the calcaneum is 
longitudinal while in forefoot it is both longitudinal and transverse. In a normal 
as well as in insensitive feet, walking briskly is accompanied by progressive 
hyperemia over points of maximum stress. Thermography helps to outline the 
temperature contrast of progressive inflammation from such a process. In 
subjects with insensitive foot thermographic pattern shows hyperemia at sites 
of old scar, there by inferring that these subjects have been stressing that 
particular area more than optimally, due to absence of pain and as a result of 
motor neuropathy. Similarly, in- shoe foot prints help to detect the points of 
persistent and maximum stress on the feet which probably could be alleviated 
by proper footwear. 
  
HEALING ULCER  
HARRIS FOOT MAT   
 
 
  
Harris mat 
The feet can be evaluated for high pressure points by means of devices 
that can quantitate the pressure under the foot during walking or standing. A 
relatively inexpensive method to establish the presence of pressure points is the 
harris foot mat. This is an ink pad with graded depths of grid lines. The patient 
walks across the pad and the pressure points can be assed by the intensity of 
the ink. This can also be fed in to a computer and a color coded analysis of 
pressure points can be obtained which is called as podio scan  
Plantar pressure measurement  
Both the rear foot and fore foot pressures are elevated in diabetics. 
Restriction of movement of subtalar joint also  leads to high plantar pressures. 
The areas of high pressure ultimately lead to tissue breakdown and ulcer 
formation. Computerized assessment of foot pressures is very important in 
assessing the changing pattern of pressure transmission in the feet Plantar peak 
pressure more than 70N / cm2 is elevated..  
Transcutaneous oximetry  
It is measured at the dorsum of foot with patient in supine position. A 
transcutaneous oxygen tension of more than 55mmHg is normal, less than 
40mm Hg leads to failure of wound healing and less than 30mm Hg predict 
limb loss. 
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CLASSIFICATION OF DIABETIC FOOT ULCERS 
Wagner classification system 
Grade Lesion 
0 No open lesions: may have deformity or cellulitis 
1 Superficial ulcer 
2 Deep ulcer to tendon or joint capsule 
3 Deep ulcer with abscess, osteomyelitis, or joint sepsis  
4 Local gangrene- forefoot or heel 
5 Gangrene of entire foot 
University of Texas classification system 
Stage Grade 
0 1 2 3 
A Pre  or post 
ulcerative 
lesions 
completely 
epithelized 
Superficial 
wound not 
involving 
tendon, capsule, 
or bone 
Wound 
penetrating to 
tendon or 
capsule 
Wound 
penetrating  to 
bone or joint 
B Infected Infected Infected Infected 
C Ischemic Ischemic Ischemic Ischemic 
D Infected and 
ischemic 
Infected and 
ischemic 
Infected and 
ischemic 
Infected and 
ischemic 
 
 
 
  
MANAGEMENT OF DIABETIC FOOT 
 
The foot ulcers in diabetics are not non healing ulcers but they are 
maltreated ulcers. Factors leading to wound healing deficiencies in diabetes are 
decreased  or impaired growth factor production, angiogenic response, 
macrophage function, collagen accumulation, epidermal barrier function, 
quantity of granulation tissue, keratinocyte and fibroblast migration and 
proliferation, poor expression of matrix metalloproteinases and their inhibitors  
(a) WAGNER grade 0 foot: 
This includes patients with apparently normal foot, varying degrees of 
neuropathy or joint deformities. They may not have any ulcer or infection but 
are potentially “at risk”. They need regular assessment atleast annually. 
Neuropathy must be looked for during each assessment. The best way to 
prevent neuropathy or delay it is to keep blood sugar under control. 
Assessment of vascular status is also mandatory. Absent foot pulses even in 
the absence of claudication or rest pain indicates significant vascular disease 
and such patients may be suitable candidates for vascular reconstruction or 
angioplasty. Remember that a diabetic may not manifest claudication 
symptoms if he had neuropathy.These “at risk” patients may have elevated 
pressure over some points on the sole. They need appropriate footwear (extra 
  
depth shoes with cushioned insoles). Charcot’s feet need custom shoes. 
Regular trimming of callus is needed. These patients also need advice 
regarding care of feet.. 
(b) WAGNER grade 1 foot: 
These are patients who have presented with either cellulitis or a superficial 
ulcer. Ulcer occurs either with repetitive low pressure or sustained high 
pressure (>6kg/cm) at that point on the sole during walking. Relief of pressure 
is the mainstay of ulcer treatment. An ulcer will not heal if the patient walks 
on it. A variety of ways are available to “off load” the ulcer. These include 
complete bed rest, use of total contact casts, walkers, braces etc. As in the case 
of grade 0 feet, appropriate management of vascular disease is needed. 
Infection needs antibiotics and debridement as appropriate. Education, foot 
care, foot wear and regular careful follow up are the principle factors in 
management of grade 1 foot. 
(c) WAGNER grade 2 and 3 foot: 
These are patients with deep ulcer with or without complications like 
abscesses and osteomyelitis. These patients need aggressive surgical 
debridement. Osteomyelitis must be appropriately managed by debridement/ 
excision of infected bone. Once the ulcer has healed, the patient needs long 
  
term care to advise appropriate foot wear and also education regarding foot 
care, in order to avoid recurrence. 
(d) WAGNER grade 4 and 5 foot: 
These are patients who have either localized or extensive gangrene. They 
need minor or major amputation respectively. Almost always there is vascular 
occlusive disease. These patients therefore need appropriate surgical 
amputation followed by vascular reconstructions. Aftercare involves special 
footwear for the ipsilateral and contralateral foot. (These patients tend to over 
use the other foot and develop ulcers of the opposite foot). In case of major 
amputees, prosthetic devices need to be fitted in order to mobilize the patient. 
Mortality rate of diabetes after a major amputation is nearly 50% at one year. 
VARIOUS TREATMENT MODALITIES  
1. Protective dressing  
Modern moist dressings include Foams, calcium alginates, hydrogels, 
hydrocolloids, and adhesive membranes 
2. Topical antiseptics  
Superoxide solutions are useful topical antiseptics which are active 
against many organisms.   
 
  
3. Drainage of pus  
Vaccum assisted drainage (continuous negative pressure of 125 mmHg)  
to the wound will promote  healing of the ulcer.   
4. Debridement 
Aggressive ongoing surgical debridement converts a chronic non healing 
ulcer in to an acute healing wound. Adequate debridement of necrotic tissue     
(eschar, slough) is needed before adequate assessment and staging can be 
accomplished. There are several methods for wound debridement, including 
sharp surgical, mechanical, enzymatic and autolytic.  It is continuum from 
flushing away debris with low pressure irrigation to wide excision.  
Sharp surgical debridement 
The most selective and efficacious method of debridement is sharp 
surgical debridement . Debridement of the hyperkeratotic rim and ulcer base to 
bleeding is the optimal method of debridement for the patient with an ulcer.  
Autolytic debridement 
Autolytic debridement with moist interactive dressings ( hydrogel , alginates, 
transparent films, hydrocolloids ) is selective and liquefies slough and eschar as 
well as promotes granulation tissue formation. 
 
  
Mechanical Debridement 
 Mechanical debridement may be accomplished with wet to dry            
gauze dressings , irrigation , pulsatile lavage or whirl pool. 
Enzymatic Debridement 
  Historical enzymes (collagenase, papain, urea) have been used as 
debriding agents for eschar and slough. They have a selective action, but are 
slow, costly and labor intensive. 
5.Antibiotic 
 The use of double or triple  antibiotics seems to be justified. The antibiotics 
used must have broader spectrum covering gram positive, gram negative and 
anaerobic organisms. 
MANAGEMENT OF INDOLENT NONHEALING ULCERS  
A.  Collagen sheets and powders 
B.  Silver dressing  
C.  Growth factors 
Growth factors are derived from platelets, bioengineered tissues or by 
recombinant techniques. 
 
 
  
PLATELET DERIVED GROWTH FACTOR (PDGF)  
             Alpha granules from platelets contains numerous growth factors. 
Platelet derived growth factor  was one of the first characterized and has led to 
an understanding of the mechanism of many growth factors. Platelet-derived 
growth factor (PDGF) regulates cell growth and division. In particular, it plays 
a significant role in blood vessel formation (angiogenesis), the growth of 
blood vessels from already-existing blood vessel tissue. In chemical terms, 
platelet-derived growth factor is dimeric glycoprotein composed of two A (-
AA) or two B (-BB) chains or a combination of the two (-AB).Though it is 
synthesized, stored and released by platelets upon activation, it is produced by 
a plethora of cells including smooth muscle cells, activated macrophages, and 
endothelial cells. There are five different isoforms of platelet derived growth 
factor  that activate cellular response through two different receptors. Known 
ligands include A (PDGFA), B (PDGFB), C (PDGFC), and D (PDGFD), and 
an AB heterodimer and receptors alpha (PDGFRA) and beta (PDGFRB) 
Mechanisms 
Platelet derived growth factor  binds to platelet derived growth factor  
receptors ligand binding pocket located within the second and third 
immunoglobulin domains. Upon activation by platelet derived growth factor  , 
these receptors dimerise, and are "switched on" by auto-phosphorylation of  
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several sites on their cytosolic domains, which serve to mediate binding 
of cofactors and subsequently activate signal transduction, for example, 
through the PI3K pathway progenitor cells. Platelet derived growth factor 
stimulates and recruits macrophages, neutrophils, and fibroblasts;stimulates 
angiogenesis, stimulates granulation tissue formation, wound contraction and 
wound remodelling. 
Uses 
 Recombinant human platelet derived growth factors is approved for 
treatment of chronic non healing wounds. Plermin gel is used in nonischemic  
clean  wounds. It is applied once daily. With appropriate wound care it increase 
the incidence of complete wound closure and decrease the  time to complete 
wound closure . 
In the study by Smiell JM and Wieman et al, a total of 922 patients have 
been studied in well designed and controlled trials and have resulted in data 
supporting safety and benefits of platelet derived growth factor application. It 
states that in diabetic foot ulcers platelet derived growth factor  gel application 
in conjunction with good wound care , significantly increased the incidence of 
complete wound closure and significantly reduced the time to complete closure 
of chronic diabetic neuropathic ulcer. 
  
In the study by Gerit D.Mulder, recombinant platelet derived growth 
factor application once a day for diabetic foot ulcers resulted in rapid 
granulation which are grafted there by avoiding limb loss. Steed e all, studied 
the effects of debridement on response to rhPDGF-BB in randomized placebo 
controlled studies. Debridement in conjunction with growth factor therapy 
resulted in statistically significant improvement between placebo and drug 
therapy. In a study by B.Amnian et al, at Shiraz University of  Medicine, 
topical application of platelet derived growth factors in chronic diabetic foot 
ulcers lead to accelerated epithelisation of wounds. 
CONTRA INDICATIONS 
The contraindications for platelet derived growth factor  usage are 
malignancy  at the site of the ulcer,  wounds that show exposed joints, tendons, 
ligaments, or  bone, an unusual or allergic reaction to plermin, parabens, 
metacresol or other  preservatives, pregnant or trying to get pregnant and 
breast-feeding. 
SIDE EFFECTS-  
Reddened skin and skin rash near ulcer are some of the side effects of 
platelet derived growth factor application.  
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D. RETROGRADE VENOUS PERFUSION TECHNIQUE 
(RVP): 
 Ferreira first introduced retrograde venous perfusion technique in 1989 
for cases of diabetic neuropathic pedal ulcers. Retrograde venous perfusion is a 
therapeutic concept based on the Bier’s principle of retrograde transvenous 
perfusion of the capillary circulation during artificially discontinued circulation 
in the extremities, ensuring a high concentration of effective substances in the 
target tissues. 
 
Mechanism of action 
Diabetic and ischemic ulcers are manifestations of breakdown in blood 
supply as a result of impairment in microcirculation and therefore remain 
resistant to systemic therapy. Retrograde venous perfusion induces a dilatation 
of venous capillaries, post capillary venules and lymphatics while arterioles 
remain unaffected. Loosening of contacts between endothelial cells and 
pericytes with focal formation of small gaps in the vessel wall enhances the 
filtration and diffusion of molecules of drugs in the interstitial tissue leading to 
a high concentration of the administered drugs in the target tissues. 
 
 
  
DRUGS  
 
 
 
VA SCULAR DOPPLER 
  
Technique of retrograde venous perfusion 
The vein in the lower leg was canulated towards the ulcer and the leg 
was elevated for 10 minutes to empty the veins. A Sphygmomanometer cuff 
was applied to the lower thigh while the leg was still elevated and inflated to a 
level higher than systolic pressure of the patient. The agent(s) to be employed 
was slowly injected into the vein, diluted in 120mL of saline. After 20 min of 
injection, pressure was released.  
Drugs used 
Combination of heparin, sodium bicarbonate, antibiotic and  lignocaine.  
a. Heparin prevents intravascular thrombosis due to venous stasis. 
b. Sodium bicarbonate combats local acidosis and makes the injection less 
painful. 
c. Intravascular lignocaine leads to reduction of vascular tone and increases 
perfusion. 
d. Specific antibiotic can be selected on the basis of culture and sensitivity.  
Advantages 
a. In a study by El Sarky Mel s et al it was proved that, retrograde venous 
perfusion does not produce cellular damage of blood and lymphatic 
vessels.  
  
b. In studies by Siedel, Jochmann etall, Brunner M Goring, the drug 
concentration in retrograde venous perfusion is reported to be 2.5–7 
times higher than by systemic intravenous infusion and three times 
higher than by a direct intra-arterial route. 
c. In systemic intravenous therapy the locally diseased arterial tree in the 
treated limb compromises delivery of the therapeutic agents to the target 
tissues. 
d.  Direct intra-arterial injection has the disadvantage of using the diseased 
arterial tree in treated limbs, particularly in patients with poor collaterals, 
as well as the risk of intimal damage leading to thrombus and embolus 
formation due to the injection. 
e.  In study by Buhler singer S ,Hiller D et al, showed that retrograde 
venous perfusion improves the cutaneous microcirculation in the 
diabetic patients, by shifting blood flow to superficial nutritive 
capillaries. 
f. Several basic and dynamic microcirculatory functions such as 
measurement of laser-doppler flux and cutaneous oxygen tension studied 
before and after retrograde venous perfusion suggest that it leads to 
remarkable improvement of the cutaneous microcirculation, suggesting a 
  
better oxygen supply to the tissues after retrograde venous perfusion 
therapy. 
g. By application of contrast medium and with the help of nuclear medicine 
studies, it has been shown that the injected fluid penetrates in a 
retrograde direction into the foot in spite of primarily intact valves.  
h. Toxicity of the employed drug is reduced in retrograde venous perfusion 
because it reaches the target tissue in therapeutic concentrations with 
relatively low doses and early fixation of drug in the target tissue. 
i. In study by Langer K, Partsch et al. retrograde venous perfusion reduces 
the time of therapy, which is associated with diminishing compliance, 
cumulative increase in cost, loss of working hours, compromised quality 
of life as well as overcoming critical complications threatening the foot.  
j. It helps in the control of acute episodes of infection, healing of ulcers, 
reversal of pre-gangrenous state and preparation of affected areas for 
surgical intervention such as skin grafting. 
Disadvantages  
The most common problem in retrograde venous perfusion therapy is 
cannulation of the vein in ischaemic limbs, rashes during the course of 
treatment, mild pain in the limb during the infusion of drugs and inflation of 
the cuff, which subsided when the cuff was released.  
  
E. Vascular management 
The vascular insufficiency in diabetes can be managed by 
pentoxyphylline, clopidogrel, Lowmolecularweight heparin for hemodilution 
and defibrogenation, vascular reconstructive surgery or balloon angioplasty  
F. OFF LOADING 
Off loading is redistribution of the mechanical force from the foot which 
helps in altering the skin and soft tissue physiology. Pressure is the causal 
factor for neuropathic foot ulcers. Therefore removal of pressure should 
facilitate healing of foot ulcers. This removal of pressure of an affected feet 
or joints can be achieved by off loading. One way of addressing this problem 
is prescribing therapeutic shoes.The more effective way to offload the fore 
foot of patients with neuropathic foot is through the use of rocker sole 
principle. The other offloading modalities are wheel chair, crutches, walker, 
total contact cast, bi-valved cast, prefabricated walking brace, Unna boot 
with walking brace, surgical shoe with insert, Pressure relieving ankle foot 
orthosis (PRAFO) and Charcot’s restraint orthotic walker (CROW) 
 
 
  
FOOTWEAR RECOMMENDATIONS IN DIABETICS 
 The recommendations are based on the following grading: 
RISK CLASS FEATURES 
0 (low risk) Has normal protective sensation 
1 (medium risk) Has neuropathy but no deformity or 
previous ulceration or amputation 
2(high risk) Neuropathy + deformity present  
But no previous ulceration or 
amputation 
3(very high risk) Neuropathy + deformity + history of 
previous ulceration or amputation 
 
Risk class 0: 
 Essentially normal patients. They need to be adviced to wear shoes with 
thick sole ( to absorb vertical compressive forces) with soft uppers ( to mould 
foot shape and avoid shoe bite) with ample toe box ( to be able to wiggle toes). 
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Risk class 1: 
 They are potential candidates for ulcerations, since they have no 
protective sensation. These patients need advice on foot care ( donot walk 
barefoot, avoid bathroom surgery, avoid extremes of temperature while 
washing feet), in addition they need foot wear that satisfies all criteria for all 
class “0” but also has a pressure dissipating accommodative insole(to avoid 
local high pressures). 
Risk class 2: 
 These are neuropathic patients with foot deformity (such as bunions, 
claw toe, hammer toe).They need a footwear with extra soft accommodative 
uppers that mould to the foot’s shape while allowing enough shape for toe 
movement. The sole may need to have recessed heel (to reduce impact at “heel 
strike” phase of gait) along with angulation of the sole just behind the 
metatarsal heads (so that a rolling motion is obtained during walking – like a  
“rocker- bottom”). A total contact insert is beneficial. 
Risk class 3: 
 These are patients who have already ulcerated once and likely to do so 
repeatedly. They need footwear recommendations as for a grade 2, well fitting 
shoes with a rocker bottom sole and moulded insole. 
  
 In case of patients with active ulceration, various options are available to 
off- load the foot. These are: total contact cast, air cast or patellar tendon 
weight bearing brace, temporary shoes( talus shoes, which has no sole in the 
front that patient walk only on heel), customized foot wear (applicable to 
patients with charcot’s foot who have disrupted bony architecture of foot). 
G. Surgical management 
This may be curative or ablative  
 Curative Surgery  
The aim of curative surgery is to remove areas of chronically increased 
peak pressure. The curative operative procedures includes  exostectomy, digital 
arthorplasty, sesemoidectomy, metatarsal head resections, joint resections, 
partial calcanectomy . 
Ablative Surgery: 
The aim of ablative surgery includes removal of all infected & necrotic 
tissue to the level of viable soft tissue and bone. Amputations may be toe 
disarticulation, fore foot amputation, Syme’s amputation , below knee 
amputation 
 
  
 NOVEL THERAPIES 
(a). Hyperbaric oxygen therapy (b) Live human skin equivalents 
produced by tissue engineering techniques which  act by filling the wound 
with extracellular matrix and inducing the expression of growth factors and 
cytokines that contribute to wound healing. Graft has both epidermal and 
lower dermal layers and contain human cells. (c).Electrical stimulation, cold 
laser and heat.  
PREVENTIVE STRATEGIES  
The International Diabetes Federation has proclaimed 2005 to be ‘The 
Year of the Diabetic Foot’. One rupee spent on prevention is equivalent to one 
million rupees saved in terms of limbs and life salvaged. Control of blood 
glucose levels is paramount in minimizing complications related to diabetes. 
Team members involved in diabetic foot care include a Podiatrist, Internist, 
Ophthalmologist , Endocrinologist, Infectious disease specialist , Cardiologist, 
Nephrologists, Vascular surgeon , Orthopedic surgeon , Nurse and Orthotist. 
Recurrent ulceration occurred in 58 % of patients whom resume wearing 
their own foot wear. Self assessment by SW filament and temperature 
assessment of the foot has been shown to reduce the incidence of foot ulcers.  
The self assessment protocol includes  
  
 Findings Category Frequency of evaluation 
Normal  Yearly 
SW filament 5/10 1 6 monthly 
SW filament 5/10 or PAD or deformity 2 3 monthly 
H/O ulcer or minor amputation 3 Monthly 
DO’s 
• Wash feet daily. 
• Inspect feet and toes, especially in  between, daily. 
• Wear thick, soft socks. 
• Cut toe -nails straight across. 
• Be measured and fitted each time you buy a new pair of shoes. 
• Lose weight. 
• Exercise. 
        DONT’s 
• Never go barefoot. 
• Avoid high heels, sandals and shoes with pointed toes. 
• Don’t smoke and drink only in moderation. 
• Avoid soaking your feet. 
• Don’t wear anything that is too tight around the legs. 
• Never use heating pads or hot water bottles on cold feet. 
• Avoid over the counter medications for corns, calluses, or warts. 
  
RESULTS 
Group A – Saline group – 25 patients 
Group B – PDGF group – 25 patients 
Group C – RGVP group – 25 patients 
Group D – Intravenous group – 25 patients 
A. PROFILE OF CASES STUDIED 
Table 1 : Age distribution 
Age group Group A  
(Saline) 
Group B 
(PDGF) 
Group C 
(RGVP) 
Group D 
(Intravenous) 
No % No % No % No % 
Upto 40 years  6 24 2 8 3 12 4 16 
41 – 50 years  7 28 5 20 6 24 9 36 
51-60 years  7 28 9 36 10 40 6 24 
Above 60 5 20 9 36 6 24 6 24 
Total 25 100 25 100 25 100 25 100 
Range  32-80 35-75 40-70 25-70 
Mean 51.1 56.7 53.3 51.2 
 
  Age of the patients included in the st
Mean age of the patients was between 51 to 57 years
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 Sex  Group A
(Saline)
No 
Male 16 
Female 9 
Total 25 
 Majority ( more than 60%) of cases in all the four groups were males. 
Table 3 : Type of Diabetes Mellitus
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Table 2 : Sex distribution 
 
  
Group B 
(PDGF) 
Group C 
(RGVP) 
% No % No % 
64 16 64 19 76 
36 9 36 6 24 
100 25 100 25 100 
 
 
 
 
 
 
 
Group 
A
Group 
B
Group 
C
Group 
D
16 16
19 19
9 9
6
0
6
MALE FEMALE
Group D 
(Intravenous) 
No % 
19 76 
6 24 
25 100 
 
 Table 3 Type of diabetes mellitus 
Type of DM Group A 
(Saline)
No 
Type 1 - 
Type 2 25 
Total 25 
 Except a single case in PDGF and another case in Intravenous Group, all 
the other 98 cases studied were of Diabetes mellitus 
0%
20%
40%
60%
80%
100%
 
 
 
 
Group B 
(PDGF) 
Group C 
(RGVP) 
% No % No % 
- 1 4 - - 
100 24 96 25 100 
100 25 100 25 100 
type 2. 
  
Group 
A
Group 
B
Group 
C
Group 
D
0 1 0 1
25 24 25
0
24
I II
Group D 
(Intravenous) 
No % 
1 4 
24 96 
25 100 
 Duration of DM 
(in years ) 
Group A
(Saline)
Range 4-
Mean 7.6
 
 Mean duration of D
was more than 7 years  
0
2
4
6
8
10
Mean duration 
(in yrs)
 
Table 4 : Duration of DM 
 
  
Group B 
(PDGF) 
Group C 
(RGVP) (Intravenous)
20 3-12 5-12 
 7.24 8.12 
iabetes Mellitus in all the diabetic foot ulcer patients 
  
Group 
A
Group 
B
Group 
C
Group 
7.6 7.24
8.12
Group D 
 
3-15 
8.8 
D
8.8
 Table 5 : S
Smoking  
(Among males) 
Group A(16) 
(Saline)
No %
Yes 8 50
No 8 50
 Among the males included in the study, percentages of smokers were 
50%, 56.3%, 26.3% and 36.8% respectively in the four groups. 
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B : RISK FACTORS 
moking ( Among males) 
 
 
Group B(16) 
(PDGF) 
Group C (19) 
(RGVP) 
 No % No % No
 9 56.3 5 26.3 
 7 43.8 14 73.7 12
 
 
 
 
 
 
 
 
Group 
A
Group 
B
Group 
C
Group 
D
8 9
5 7
8 7
14 12
NO YES
Group D(19) 
(Intravenous) 
 % 
7 36.8 
 63.2 
 HTN Group A 
(Saline)
No 
Present 16 
Absent 9 
Hypertension was present in more than 50% of the patients with diabetic foot 
ulcers. 
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16
9
ABSENT
 
Table 6 : Hypertension 
 
 
Group B 
(PDGF) 
Group C 
(RGVP) 
% No % No % 
64 12 48 14 56 
36 13 52 11 44 
  
Group 
B
Group 
C
Group 
D
12 14 12
13 11 13
PRESENT
Group D 
(Intravenous) 
No % 
12 48 
13 52 
 Table 
PN Group A 
(Saline)
No 
Present 25 
Absent 0 
0
5
10
15
20
25
Group A
Peripheral  neuropathy
 
7 : Peripheral Neuropathy  
 
 
Group B 
(PDGF) 
Group C 
(RGVP) 
% No % No % 
100 25 100 25 100 
0 0 0 0 0 
 
 
 
Group B Group C Group D
Present Absent 
Group D 
(Intravenous) 
No % 
25 100 
0 0 
 
 ABI values 
right 
Group A 
(Saline)
Range 0.6-
Mean 0.79
S.D 0.15
 Mean ABI – right values were
4 Groups. 
0
0.2
0.4
0.6
0.8
1
Mean ABI-Right
 
Table 8 : ABI values right 
 
 
Group B 
(PDGF) 
Group C 
(RGVP) (Intravenous)
1 0.6-1 0.6-1 
 0.73 0.75 
 0.11 0.13 
 less than the normal value (0.8
Group 
A
Group 
B
Group 
C
Group 
D
0.79
0.73 0.75 0.76
Group D 
 
0.6-1 
0.76 
0.15 
) in all the 
 ABI – Left Group A 
(Saline)
Range 0.6-1.0
Mean 0.7 
S.D 0.1 
 Mean ABI – left values were
Groups. 
0
0.2
0.4
0.6
0.8
1
0.7
Mean ABI-Left
 
Table 9 : ABI - Left 
 
 
Group B 
(PDGF) 
Group C 
(RGVP) (Intravenous)
 0.6-1.0 0.5-1.0 
0.74 0.72 
0.13 0.14 
 less than the normal value (0.8
Group 
A
Group 
B
Group 
C
Group 
D
0.74
0.72 0.72
Group D 
 
0.6-1.0 
0.72 
0.11 
) in all the 4 
  
C : COMPARATIVE EFFICACY OF SALINE AND PDGF METHODS 
Table 10 : Ulcer area at different times 
Ulcer area  
(cm2) at 
Mean + SD for ‘p’ 
Saline group  PDGF group 
0 day 62.7 + 28.3  53.2 + 25.6 0.2297 Not significant 
7th day 55.2  + 27.6 35 + 20 0.0088 Significant 
14th day 52.8 + 27.5 28.7 + 22 0.0017 Significant 
21st day 43.9 + 26.8 22 + 18.4 0.0035 Significant 
28th day 41.7 + 29 21.2 + 20.9 0.0063 Significant 
Decrease in 28 
days  
24.0 + 18.6 36.9 + 16.5 0.0127 Significant 
 
 Ulcer area was 62.7 + 28.3 sq.cms2 on the day of first visit and it was 
reduced by 24.0 + 18.6 to 41.7 + 29 sq.cms2 at the end of four weeks in the 
saline group. But the decrease was more (36.9 + 16.5) in the PDGF group. This 
difference was statistically significant (p=0.0127). 
  
Ulcer area at different times 
 
 
 
 
 
 
 
 
Table 11 : Healing time for completely healed cases 
Healing time for completely 
healed cases (in days) 
PDGF group  
(8 cases) 
Saline group 
Range 18-20days 24-26 
Mean 19 25.0 
 
 Two cases in the saline group and 8 cases in the PDGF group were 
completed healed.  
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SALINE GROUP PDGF GROUP
 Type of healing
Completely healed
Improved  
Partly healed 
Worsened  
P 
 80% of cases in PDGF group were improved or completely healed 
whereas this figure was on
significantly ( p = 0.0007) more effective in healing than saline group.
SALINE GROUP
PDGF GROUP
Completely healed
 
Table  12 : Type of healing  
 Saline group PDGF group
No % No 
 2 8 8 
5 20 12 
 15 60 5 
3 12 - 
0.0007  
Significant 
ly 28% for saline group. Thus P
0% 20% 40% 60% 80% 100%
2
8
5
12
15
5
3
Improved Partly healed
 
% 
32 
48 
20 
- 
DGF was 
 
0
Worsened
  
Table 13 : Split Skin Grafting / Amputation 
SSG / AMP Saline group PDGF group 
No % No % 
SSG 
Done  
Not done 
 
5 
20 
 
20 
80 
 
8 
17 
 
32 
68 
P 0.519  
Not significant 
Amputation 
Done 
Not done 
 
- 
25 
 
- 
100 
 
- 
25 
 
- 
100 
p 1.0  
Not significant 
 
 SSG was done for 5 cases in saline group and 8 cases in PDGF group. 
Amputation was not done for any case in both groups. 
  
D : COMPARATIVE EFFICACY OF RGVP AND INTRAVENOUS 
GROUPS 
Table 14 : Ulcer area at different times 
 
Ulcer area  
(cm2) at 
Mean + SD for ‘p’ 
RGVP 
group  
Intravenous 
Group 
0 day 50.9 +18.8 61.0 +23.1 0.1785 Not significant 
7th day 26.5 +14.7 46.2 +19.3 0.0004 Significant 
14th day 18.9 +11.1 43 +23 0.0001 Significant 
21st day 15.4 +9.2 35.5 +22.7 0.0003 Significant 
28th day 11 +9.9 31.3 +19.4 0.0001 Significant 
Decrease in 28 
days  
41.9 +13.9 29.8 +12.8 0.0046 Significant 
 
 Ulcer area was 50.9 +18.8 cms2 in RGVP group was reduced to11 +9.9 
sq.cms2 at the end of 4 weeks of treatment. But in the intravenous group it was 
reduced from 61+ 23.1 sq.cms2 to 29.8 +12.8 sq.cms2. The reductions were 
41.9 +13.9 and 29.8 +12.8 sq.cms2. The difference in reduction of ulcer area 
was statistically significant (p=0.0046) substantiating the better efficacy at 
RGVP over intravenous treatment. 
 
  
Ulcer area at different times 
 
 
 
 
 
 
 
 
 
Table 15 : Healing time for completely healed cases  
Healing time RGVP group Intravenous group 
Range 13- 18 days - 
Mean 16 days  - 
 Note : None of the cases in the intravenous group were completely 
healed. 
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 84% of cases in RGVP group were improved or completely healed 
whereas only 24% in intravenous group were improved. Type of healing was 
significantly better in RGVP group. ( p = 0.0001).
  
 
 
 
 
RGVP GROUP
INTRAVENOU
Completely healed
 
Table 16 : Type of healing  
 RGVP group Intravenous 
group
No % No 
 5 20 - 
16 64 6 
4 16 17 
- - 2 
0.0001  
Significant 
 
 
 
0% 20% 40% 60% 80% 100%
…
5
0
16
6
4
17 2
Improved Partly healed Worsened
 
% 
- 
24 
68 
8 
0
  
Table 17 : SSG / Amputation 
SSG / Amputation RGVP group Intravenous 
group 
No % No % 
SSG 
Done  
Not done 
 
2 
23 
 
8 
92 
 
3 
22 
 
12 
88 
p 0.5 Not significant 
Amputation 
Done 
Not done 
 
- 
25 
 
- 
100 
 
- 
25 
 
- 
100 
p 1.0 Not significant 
 
 Two cases in RGVP group and three in intravenous group were done 
SSG. None of the cases were amputated. 
 
 
 
  
DISCUSSION AND ANALYSIS 
Age and Sex 
In our study foot ulcers were more common in male population that too 
between the age group of 50-60 years. This shows the nature of work in males 
and the amount of trauma they are subjected to.  
Type and Duration of Diabetes  
Most of the patients in our study are suffering from type 2 diabetes and 
the mean duration of diabetes was more than 7  years . This longer duration of 
diabetes is directly proportional to the development of  complications of 
diabetes  like neuropathy and vasculopathy which are significant precursors for 
foot ulcers . 
Risk factors  
Smoking as an individual risk factor for diabetic foot ulcer can not be 
emphasized much. Instead, it accelerates the development of vasculopathy 
which is a forerunner of foot ulcers. Nearly 50% of the patients in our study 
had an associated hypertension which in turn accelerates diabetic changes in 
the tissues at a more rapid pace thereby indirectly leading to foot ulcers. 
 
  
Neuropathy and vasculopathy 
As it is well described in literatures, sensory neuropathy is one of the 
most important causative  factor  for development of foot ulcers in diabetics. 
Our study also confirms the above fact that nearly all our patients had sensory 
neuropathy.  Vasculopathy, a major pathophysiological factor for diabetic foot 
ulcers was present in about 80% of  our  patients and  in all of them the  mean 
ABI was  ≤ 0.8.  
PDGF VS SALINE GROUPS  
In studies by smiell JM, and wieman et al. and Steed et al., daily 
application of platelet derived growth factor in diabetic foot ulcers resulted in 
significant earlier reduction in ulcer area.  
In our study also there was a statistically significant  reduction in ulcer 
area of  more than  40cm2  by 4th week after application of platelet derived 
growth factor when compared to only 24cm2 saline dressing group.  
 The effective wound healing with  application of platelet derived growth 
factor  was proven by the fact that nearly 80% of the ulcers treated with platelet 
derived growth factor were either improved or got healed completely ,while 
only 28% of ulcers got improved in the case of saline dressing . 
  
 In completely healed wounds the healing time was only 19 days in 
platelet derived growth factor group when compared to 25 days in saline group. 
In patients who were in the improved group the graft bed was better 
prepared for skin grafting much earlier with  dressing platelet derived growth 
factor than with saline dressing .  Hence in larger wounds the platelet derived 
growth factor dressing provides early and effective wound healing thereby 
avoiding the need for an extensive skin grafting. Amputations were not done in 
any of our patients. Platelet derived growth factor dressing is really an useful 
adjunct and limb salvaging modality in the management of nonhealing diabetic 
foot ulcers. 
RETROGRADE VENOUS PERFUSION VS INTRAVENOUS 
ANTIBIOTIC GROUPS 
The prevalence of infection both the groups were similar as proven by 
positive cultures from the wound swabs. The effective concentration of 
antibiotic reaching the ulcer site is much better in the retrograde venous 
perfusion group compared to intravenous group. This was reflected by the 
reduction in ulcer area by 28 days was 41cm2 in the retrograde venous 
perfusion group compared to only 29 cm2 in the intravenous group. 
  
 Nearly about 80% of the patients in the retrograde venous perfusion  
group showed a statistically significant reduction in ulcer area compared to 
only 24% in the  intravenous group. 
Since effective control of infection is possible with retrograde venous 
perfusion of antibiotic the ulcer healing occurs much earlier . About 5 patients 
in retrograde venous perfusion had complete healing of ulcer by 3rd to 4tn week. 
  Skin grafting was done for 2 patients in retrograde venous perfusion 
group and none of these patients underwent any sort of amputations. Hence 
retrograde venous perfusion of antibiotics offers an added advantage of 
effective drug concentration at the wound site and a better and faster wound 
healing compared to systemic antibiotic therapy. 
PRVENTIVE STRATEGIES  
All the patients in our study are screened for the presence high risk 
pressure points in the same as well as the opposite foot . Special foot wears 
were prescribed to all our patients to prevent further ulcers in the same or at 
others sites in their foot.  Education regarding foot care was given to all of 
them and they were advised to come for regular follow up. 
 
  
CONCLUSION 
Diabetes mellitus which is already a public health problem needs to be 
addressed more effectively. The foot problems in diabetics pose a challenge not 
only to the treating surgeon but to the entire society. Hence many newer 
modalities of treatment are being introduced in the management of diabetic 
foot. There is a changing trend towards adopting limb salvaging procedures 
thereby avoiding amputations as far as possible. 
In our study, foot ulcers were more common in male population, with 
fairly longer duration of diabetes. This signifies the nature of work that males 
in our society are exposed to and also the prolonged periods needed for the 
development of complications of diabetes which are precursors for ulcers in 
these individuals.  
Peripheral neuropathy and vasculopathy are independent risk factors for 
the development of diabetic ulcers. In our study nearly all the patients had 
neuropathy and about 80% of our patients had vasculopathy. Hence an 
adequate control of diabetes by all means is needed to prevent the development 
of these risk factors in a diabetic individual. 
Platelet derived growth factor one of the newer inventions, promotes 
faster and effective wound healing in diabetic foot ulcers. It’s usefulness in 
  
bringing down the ulcer area is much better than other modalities of treatment.  
According to our statistical data, about 80% of the ulcers either improved or 
healed by 4 weeks time which also  goes in favour of these statements 
regarding platelet derived growth factor.  
Infection one of the bad prognostic indicator of diabetic ulcer healing 
needs to be treated more effectively. Retrograde venous perfusion of antibiotics  
shows more promising results in that it delivered an effective concentration of 
antibiotics at the wound site thereby promoting ulcer healing in much better 
and faster rate. Hence these  platelet derived growth factor dressing and 
retrograde venous perfusion of antibiotics  are better limb salvaging techniques 
which can be employed in day to day practice   
All the patients in our study are screened for the presence high risk 
pressure  points  in  the  same as well as the opposite foot . Special foot wears 
were prescribed to all our patients to prevent further ulcers in their foot.  
Education regarding foot care which is utmost important in diabetic foot 
management is given to all of them . 
By adequate control of blood sugar, proper foot care ,and judicious use 
of modalities like platelet derived growth factor application and retrograde 
venous perfusion of antibiotics most of the diabetic limbs can be saved .  
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PROFOMA 
 Name                 :  
Age                :  
Sex     :   Male / Female  
Ip / Op No.    :  
DOA     :  
DOD    : 
 Type of DM    :   Type 1 / Type 2  
 Duration of DM  :  
 Comorbidities and Risk factors :   Smoking / HTN/ IHD 
Treatment     :   OHA / Insulin/ Insulin +OHA / Antiplatelets  
Peripheral Sensory Neuropathy  :   Present /Absent 
 Vasculopathy  (ABI )  : 
Right Left 
  
Infection   :  Present / Absent  
 
 Ulcer area( cm2)
    
 
 Ulcer healing time(Days) 
  : 
 
 Ulcer healing time(Days)
  :  
 
Type of healing   :  A  / B / C /  D 
SSG    :  Done / Not done  
Amputation   :  Done / Not done 
Day o Day 7 Day 14 Day 21 Day 28 
     
RGVP group Intravenous group 
  
PDGF group Saline dressing group 
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1 A Sivakumar 40 1 41655 2 5 P P Insuli
n 
 + 1 0.7 A 10
0 
90 90 80 80  C ND ND 
2 A kuppusamy 66 1 65324 2 6 A P Insuli
n 
 + 0.7 0.6 A 80 80 70 70 50  C ND ND 
3 A Meenakshi 
sundaram 
34 1 70237 2 5 P A Insuli
n 
 + 0.8 0.7 A 90 80 80 60 60  C ND ND 
4 A Alagar 35 1 75072 2 6 P P Insuli
n 
 + 0.7 0.8 A 80 70 60 45 15  B D ND 
5 A Paulraj 65 1 76718 2 10 A P Insuli
n 
 + 0.7 0.6 A 10
0 
10
0 
90 90 10
0 
 D ND ND 
6 A Bose 56 1 81238 2 8 P P Insuli
n 
 + 1 0.8 A 60 50 60 30 10  B D ND 
  
7 A Subbiah 80 1 84619 2 20 A P Insuli
n 
 + 0.7 1 A 50 45 45 25 10  B D ND 
8 A Renga 42 1 86236 2 5 P P Insuli
n 
 + 0.8 0.6 A 24 20 20 15 15  C ND ND 
9 A Narkarunai 52 1 89151 2 4 P P Insuli
n 
 + 0.7 0.6 A 60 60 40 30 10  B D ND 
10 A vijayaraj 32 1 89252 2 4 A A Insuli
n 
 + 1 0.8 A 36 26 26 24 24  C ND ND 
11 A sengol 50 1 531353 2 5 A A Insuli
n 
 + 0.6 0.7 A 12
0 
10
0 
10
0 
80 80  C ND ND 
12 A sivan 50 1 53145 2 8 A P Insuli
n 
 + 1 0.6 A 40 40 30 10 5  B D ND 
13 A ganesh 54 1 18721 2 8 A P Insuli
n 
 + 0.7 0.6 A 40 30 30 25 25  C ND ND 
14 A chandrasekaran 51 1 88351 2 7 P A Insuli
n 
 + 1 0.7 A 64 56 56 48 40  C ND ND 
15 A ilayaraja 39 1 38078 2 4 P A Insuli
n 
 + 0.6 0.7 A 24 20 20 20 15  C ND ND 
16 A sudhakar 45 1 15791 2 8 A A Insuli
n 
 + 0.9 0.8 A 90 80 70 70 55  C ND ND 
  
17 A irulayee 58 2 75188 2 10 A P Insuli
n 
 + 1 0.6 A 80 70 60 50 50  C ND ND 
18 A ponnalagu 40 2 76496 2 5 A A Insuli
n 
 + 0.7 0.7 A 80 80 90 90 90  D ND ND 
19 A malayalam 60 2 78479 2 12 A P Insuli
n 
 + 1 0.6 A 50 50 60 60 65  D ND ND 
20 A deraviam 63 2 79688 2 12 A P Insuli
n 
 + 0.8 0.7 A 10
0 
90 90 70 70  C ND ND 
21 A muthulakshmi 45 2 83173 2 10 A A Insuli
n 
 + 0.7 0.8 A 20 10 10 5  - 22 A ND ND 
22 A pappathi 55 2 86382 2 5 A P Insuli
n 
 + 0.6 0.8 A 36 24 12 4  - 24 A ND ND 
23 A shenbagam 45 2 89209 2 5 A A Insuli
n 
 + 0.7 0.7 A 60 50 50 40 40  C ND ND 
24 A Pappa 70 2 89468 2 10 A P Insuli
n 
 + 0.6 0.8 A 24 20 20 20 15  C ND ND 
25 A mangayar 
thilagam 
50 2 90769 2 8 A P Insuli
n 
 + 0.8 0.6 A 60 40 40 36 36  C ND ND 
26 B Kumar 44 1 892941 2 5 P P Insuli
n 
 + 0.6 0.9 A 24 16 16 10 5  B D ND 
  
27 B lakshmanan 75 1 92172 2 12 A P Insuli
n 
 + 0.7 0.7 A 24 16 8  -  - 20 A ND ND 
28 B nagappan 65 1 92235 2 7 P P Insuli
n 
 + 0.7 1 A 36 24 12 10 5  B D ND 
29 B sivalingam 61 1 4863 2 8 A A Insuli
n 
 + 0.8 0.8 A 50 25 25 10 5  B ND ND 
30 B samyvel 60 1 23516 2 7 P A Insuli
n 
 + 0.7 0.6 A 30 20 10 5  24 A ND ND 
31 B ayyappan 60 1 31068 2 6 A A Insuli
n 
 + 0.6 0.7 A 10
0 
70 60 40 15  B ND ND 
32 B marimuthu 35 1 31746 2 3 P A Insuli
n 
 + 0.8 0.6 A 28 20 8  -  - 18 A ND ND 
33 B pondi 50 1 38346 2 6 P A Insuli
n 
 + 0.7 0.7 A 80 60 40 20 10  B ND ND 
34 B michel raj 57 1 44850 2 6 A P Insuli
n 
 + 0.6 0.7 A 40 30 12 4  - 26 A ND ND 
35 B karrupiah 60 1 40540 2 7 A A Insuli
n 
 + 1 0.6 A 50 25 25 15 10  B ND ND 
36 B ramachandran 62 1 88351 2 8 P P Insuli
n 
 + 0.7 0.8 A 80 60 60 50 55  C ND ND 
  
37 B mahesvaran 41 1 39403 2 10 A A Insuli
n 
 + 0.6 0.6 A 24 12 8 - -  A ND ND 
38 B sangilimuthu 35 1 21541 1 6 P A Insuli
n 
 + 0.8 0.7 A 80 60 60 50 50  C ND ND 
39 B gurusamy 55 1 398142 2 10 P A Insuli
n 
 + 0.8 1 A 50 40 15 10 10  B D ND 
40 B veerananan 70 1 38925 2 12 P P Insuli
n 
 + 0.7 0.6 A 36 24 12 8  - 27 A ND ND 
41 B sikander 45 1 81256 2 4 A P Insuli
n 
 + 0.7 0.9 A 10
0 
70 70 60 60  C ND ND 
42 B lakshmiammal 55 2 90276 2 10 A P Insuli
n 
 + 0.6 0.7 A 50 25 15 10 5  B D ND 
43 B indhumathi 54 2 93541 2 5 A A Insuli
n 
 + 0.8 0.8 A 60 30 30 15 10  B D ND 
44 B chinnammal 65 2 30701 2 7 A P Insuli
n 
 + 0.8 0.8 A 40 20 10 5  - 26 A ND ND 
45 B pethiammal 45 2 77539 2 7 A A Insuli
n 
 + 0.7 0.6 A 18 12 6  -  - 18 A ND ND 
46 B vijayaraj 60 2 9538 2 8 A P Insuli
n 
 + 0.7 1 A 50 25 25 15 10  B D ND 
  
47 B lakshmiammal 70 2 7618 2 8 A A Insuli
n 
 + 0.7 0.7 A 40 20 20 10 5  B D ND 
48 B jothi 55 2 25288 2 7 A P Insuli
n 
 + 1 0.6 A 80 60 60 45 45  C ND ND 
49 B pandiammal 74 2 30092 2 5 A P Insuli
n 
 + 0.8 0.8 A 60 40 40 20 10  B D ND 
50 B vairathai 65 2 33094 2 7 A A Insuli
n 
 + 0.7 0.7 A 10
0 
70 70 50 50  C ND ND 
51 C Mani 61 1 51384 2 8 A A Insuli
n 
 + 1 0.8 A 70 40 20 10 5  B ND ND 
52 C sankar 45 1 85601 2 8 P P Insuli
n 
 + 0.6 0.6 A 50 30 25 25 20  C ND ND 
53 C duraipandi 62 1 52681 2 7 P A Insuli
n 
 + 0.7 0.7 A 60 20 20 10 5  B ND ND 
54 C arumugam 53 1 62621 2 12 P P Insuli
n 
 + 0.6 0.8 A 50 25 25 10 5  B ND ND 
55 C pondiaraj 64 1 56021 2 10 A A Insuli
n 
 + 0.8 1 A 80 60 40 20 10  B ND ND 
56 C raju 45 1 66607 2 7 A A Insuli
n 
 + 0.6 0.8 A 60 40 15 10 10  B ND ND 
  
57 C mahalingam 55 1 45231 2 7 A P Insuli
n 
 + 0.8 0.6 A 40 24 12 10 5  B ND ND 
58 C ramachandran 62 1 88531 2 8 A A Insuli
n 
 + 0.7 0.7 A 50 20 20 10 5  B ND ND 
59 C mohan 40 1 78991 2 7 A A Insuli
n 
 + 0.6 0.6 A 24 12 4   16 A ND ND 
60 C sivamurugan 56 1 52681 2 8 A P Insuli
n 
 + 0.7 0.7 A 60 40 15 10 10  B ND ND 
61 C pandi 55 1 32186 2 6 A A Insuli
n 
 + 0.7 0.6 A 70 40 20 20 10  B ND ND 
62 C kaleswaran 52 1 38126 2 5 A P Insuli
n 
 + 0.9 0.5 A 44 10 10 10 5  B ND ND 
63 C balan 46 1 52621 2 10 P P Insuli
n 
 + 0.8 0.8 A 90 60 45 40 40  C ND ND 
64 C sankar 70 1 14108 2 7 A P Insuli
n 
 + 0.7 0.5 A 70 30 30 15 10  B D ND 
65 C ramani 40 1 28102 2 7 A P Insuli
n 
 + 0.7 0.8 A 50 20 15 10 5  B D ND 
66 C subramaniam 54 1 241836
1 
2 10 A P Insuli
n 
 + 0.6 0.6 A 24 10 4   18 A ND ND 
  
67 C kanagaraj 52 1 65212 2 7 A P Insuli
n 
 + 0.8 0.8 A 30 15 5   17 A ND ND 
68 C cheelaiah 60 1 90164 2 7 A P Insuli
n 
 + 0.8 0.6 A 16 4    13 A ND ND 
69 C karuppasamy 52 1 98947 2 12 P P Insuli
n 
 + 0.7 0.9 A 64 32 32 30 25  C ND ND 
70 C mariyammal 65 2 28798 2 12 A A Insuli
n 
 + 0.6 0.8 A 42 16 12 10 5  B ND ND 
71 C kaliammal 50 2 39814 2 10 A A Insuli
n 
 + 1 0.6 A 40 20 10 10 5  B ND ND 
72 C pappa 60 2 74576 2 8 A P Insuli
n 
 + 0.9 0.7 A 70 40 35 30 30  C ND ND 
73 C subbammal 43 2 89650 2 7 A A Insuli
n 
 + 1 0.6 A 48 18 18 12 5  B ND ND 
74 C meenakshi 50 2 360963 2 6 A A Insuli
n 
 + 0.7 1 A 24 12 10   16 A ND ND 
75 C maheswari 40 2 32226 2 7 A P Insuli
n 
 + 0.8 0.9 A 46 24 12 5 5  B ND ND 
76 D Edison paul 70 1 56616 2 10 P P Insuli
n 
 + 0.7 0.7 A 80 70 70 50 50  C ND ND 
  
77 D ramaiah 55 1 56213 2 10 A A Insuli
n 
 + 0.6 1 A 60 40 40 20 25  C ND ND 
78 D sermakani 64 1 45751 2 12 A P Insuli
n 
 + 1 0.6 A 42 28 28 20 20  C ND ND 
79 D thajudeen 29 1 24699 2 3 P P Insuli
n 
 + 0.7 0.8 A 28 20 20 18 18  C ND ND 
80 D vijayaraj 45 1 43723 2 6 A P Insuli
n 
 + 0.6 0.6 A 10
0 
70 70 60 60  C ND ND 
81 D marriappan 50 1 28410 2 8 P A Insuli
n 
 + 1 0.7 A 40 20 20 10 5  B ND ND 
82 D baskaran 32 1 43126 2 5 P P Insuli
n 
 + 0.6 0.8 A 28 20 20 16 16  C ND ND 
83 D gandhi 49 1 31181 2 8 A P Insuli
n 
 + 0.7 0.7 A 42 28 28 20 20  C ND ND 
84 D raja 67 1 67037 2 8 A A Insuli
n 
 + 0.6 0.8 A 40 30 25 25 20  C ND ND 
85 D mayan 69 1 249024 2 10 A A Insuli
n 
 + 0.8 0.6 A 30 24 12 10 5  B ND ND 
86 D nagaraj 45 1 53921 2 12 A P Insuli
n 
 + 1 0.9 A 50 40 15 15 10  B ND ND 
  
87 D manoharan 60 1 33851 2 8 A A Insuli
n 
 + 0.7 0.6 A 80 60 45 40 40  C ND ND 
88 D muthu 25 1 34621 1 10 P P Insuli
n 
 + 0.8 0.7 A 80 80 70 60 50  C ND ND 
89 D sankaran 70 1 66513 2 12 A P Insuli
n 
 + 0.6 0.6 A 48 48 50 54 54  D ND ND 
90 D veerapandi 43 1 56365 2 8 P A Insuli
n 
 + 1 0.7 A 50 40 15 10 10  B D ND 
91 D muthupandi 42 1 69546 2 8 P A Insuli
n 
 + 0.7 0.6 A 10
0 
70 70 60 50  C ND ND 
92 D jeyaraman 52 1 98947 2 6 A A Insuli
n 
 + 0.8 0.7 A 80 60 60 55 55  C ND ND 
93 D nachiappan 55 1 78650 2 7 A A Insuli
n 
 + 0.7 0.8 A 80 60 60 50 50  C ND ND 
94 D mohideen 60 1 74210 2 7 A A Insuli
n 
 + 0.7 0.7 A 48 36 36 24 24  C ND ND 
95 D panchammal 68 2 36814 2 10 A P Insuli
n 
 + 0.9 0.6 A 10
0 
80 10
0 
10
0 
60  D ND ND 
96 D chandra 53 2 48189 2 10 A P Insuli
n 
 + 0.6 0.7 A 80 60 60 50 50  C ND ND 
  
97 D guruvammal 48 2 78290 2 8 A A Insuli
n 
 + 0.8 0.6 A 40 40 30 20 15  B D ND 
98 D anandhi 36 2 98176 2 7 A A Insuli
n 
 + 1 0.8 A 60 30 30 25 10  C D ND 
99 D alagammal 46 2 42986 2 15 A P Insuli
n 
 + 0.8 0.8 A 60 40 40 20 15  B ND ND 
100 D sudha 46 2 64641 2 12 A A Insuli
n 
 + 0.6 0.8 A 80 60 60 55 50  C ND ND 
  
 
